The IPO was a disappointment - Will the turnaround happen?
Announced insider purchases of up to 12 million euros could help regain investors' trust!
The IPO was a disappointment. Now the company must demonstrate whether fundamental developments can justify higher prices!
Reading Time: 1 minute
Innoscripta SE (i.) has disappointed investors during the IPO. On one hand, the company did not raise fresh capital itself but only conducted a "secondary listing," in which only existing shares from previous shareholders (founders and owners) were sold. On the other hand, there were no positive impulses or supporting purchases immediately after the IPO, causing the stock to plummet. In response, the two main shareholders have announced plans for share purchases of up to 12 million euros. If the company can regain the trust of investors in the future...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
